Literature DB >> 14499817

Recent advances in uveitis of juvenile idiopathic arthritis.

Kaisu Kotaniemi1, Anneli Savolainen, Anni Karma, Kimmo Aho.   

Abstract

Chronic scarring-type uveitis is a frequent extra-articular manifestation of juvenile idiopathic arthritis. It occurs in about 20% of children with this disease, commencing typically within a few years from its onset. The risk of uveitis is greatest in antinuclear antibody-positive girls with early onset oligoarthritis. The classic clinical picture is chronic bilateral anterior uveitis, usually asymptomatic until substantial damage to intraocular structures occurs. In view of the asymptomatic nature of the condition, routine screening of juvenile idiopathic arthritis patients 2-4 times a year is crucial to prevent complications. The treatment consists of topical corticosteroids and mydriatics, in severe cases with immunosuppressive agents, and surgical management of complications. Although the prognosis of uveitis is improving, there are cases refractory to standard regimens. Patients in whom uveitis commences prior to the onset of arthritis present a special problem.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499817     DOI: 10.1016/s0039-6257(03)00084-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  30 in total

1.  Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis.

Authors:  Nihal Kenawy; Gavin Cleary; Devesh Mewar; Nicholas Beare; Arvind Chandna; Ian Pearce
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-05       Impact factor: 3.117

2.  Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.

Authors:  Fasika Woreta; Jennifer E Thorne; Douglas A Jabs; Sanjay R Kedhar; James P Dunn
Journal:  Am J Ophthalmol       Date:  2006-12-20       Impact factor: 5.258

3.  Recurrent hypopyon in chronic anterior uveitis of pauciarticular juvenile idiopathic arthritis.

Authors:  J H Chang; P J McCluskey; J R Grigg
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

4.  Adalimumab in the therapy of uveitis in childhood.

Authors:  Ahmad M Mansour
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

Review 5.  Ophthalmic manifestations of rheumatologic disease: diagnosis and management.

Authors:  Carisa K Petris; Arghavan Almony
Journal:  Mo Med       Date:  2012 Jan-Feb

6.  Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.

Authors:  Jennifer E Thorne; Fasika A Woreta; James P Dunn; Douglas A Jabs
Journal:  Ophthalmology       Date:  2010-04-03       Impact factor: 12.079

Review 7.  Noninfectious immune-mediated uveitis and ocular inflammation.

Authors:  Jennifer Pan; Manuj Kapur; Rex McCallum
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 8.  Prevention and management of cataracts in children with juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila Angeles-Han; Steven Yeh
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

9.  An evaluation of dry eye symptoms and signs in a cohort of children with juvenile idiopathic arthritis.

Authors:  Kaisu M Kotaniemi; Pirjo M Salomaa; Kristiina Sihto-Kauppi; Hanna M Säilä; Markku J Kauppi
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  Adalimumab for juvenile idiopathic arthritis-associated uveitis.

Authors:  Adriano Magli; Raimondo Forte; Pasqualina Navarro; Giustina Russo; Francesca Orlando; Loredana Latanza; Maria Alessio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-01       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.